Betamethasone Sodium Phosphate and Betamethasone Acetate
- Product NDC
- 70518-2952
- 11-digit product format
- 705182952
- Labeler code
- 70518
- Product ID
- 70518-2952_d79bc7a3-ff12-7d45-e053-2a95a90a4e9a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Betamethasone Sodium Phosphate and Betamethasone Acetate
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE
- Labeler
- REMEDYREPACK INC.
- Application
- NDA014602
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2020-12-01
- Marketing end
- 0000-00-00
- Substance
- BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE
- Active strength
- 3 mg/mL; mg/mL
- Pharmacologic classes
- Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Corticosteroid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2952-0 | 70518295200 | 1 VIAL, MULTI-DOSE in 1 BOX (70518-2952-0) > 5 mL in 1 VIAL, MULTI-DOSE | 2020-12-01 | 0000-00-00 | No | No | Current |